The "Bridging the Swarm" mission lifted off on Thursday (Jan. 29) at 8:21 p.m. ET. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Breaking space ...

Breaking space news, the latest updates on rocket launches, skywatching events and more! You are now subscribed Your newsletter sign-up was successful Want to add more newsletters? Breaking space news ...

The lower half of the New Glenn rocket set down on a platform in the Atlantic Ocean after lifting a small NASA Mars mission to space. By Kenneth Chang Kenneth Chang reported on the first flight of the ...

Rocket Lab Corp. delayed the first launch of its larger Neutron rocket until next year, a setback in the space transportation company’s push to compete more directly with Elon Musk’s SpaceX. The Long ...

OpenAI on Thursday announced it has acquired Software Applications Incorporated, a small company that developed a Mac product called Sky. All employees from Software Applications will join OpenAI.

On Tuesday, the U.S. Food and Drug Administration (FDA) accepted Rocket Pharmaceuticals, Inc.’s (NASDAQ:RCKT) resubmission of the Biologics License Application (BLA) for Kresladi (marnetegragene ...

Rocket Pharmaceuticals (NASDAQ:RCKT) reported that it has voluntarily withdrawn its biologics marketing application to the U.S. FDA for mozafancogene autotemcel or RP-L102, an investigational gene ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Rocket Pharmaceuticals ( (RCKT)) just ...

Oct 3 (Reuters) - Rocket Pharmaceuticals (RCKT.O), opens new tab said on Friday it has withdrawn its application for U.S. approval of its experimental gene therapy for a rare inherited blood disorder.

Having already altered the journey of its rare disease gene therapy to a hoped-for FDA approval, Rocket Pharmaceuticals has now aborted the mission entirely. The biotech initiated a rolling biologics ...

Rocket Pharmaceuticals has withdrawn its application seeking Food and Drug Administration approval of its RP-L102 proposed gene therapy for the treatment of the rare, inherited blood disorder Fanconi ...

Seed Round Led by Salesforce Ventures and Accel, with participation from Together Fund to Power Global Expansion SURAT, India , Sept. 23, 2025 /PRNewswire/ -- Rocket, the AI-powered app-building ...